吸入的microcystin-LR可能会通过肝脏拥堵诱导急性肝功能衰竭
Wonkyun Jung1, Mi-Jin Yang2, Su-Hyeon Jo1
1Department of Biomedical Science, College of Medicine, Kyung Hee University, Seoul, Republic of Korea; Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, Core Research Institute, Kyung Hee University, Seoul, Republic of Korea.
Ecotoxicology and environmental safety
|November 9, 2025
概括
吸入的微囊素-氨酸-氨酸 (MC-LR) 毒素来自蓝色细菌的开花是一个日益增长的公共卫生风险. 研究表明,MC-LR在小鼠中引起肝毒性和潜在死亡,可接受的吸入剂量可能低于10μg/kg.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
背景情况:
- 气候变化正在增加蓝藻细菌的繁殖,导致环境对微素-氨酸-氨酸 (MC-LR) 的暴露越来越大.
- MC-LR是一种由蓝菌产生的强毒素,由于人类潜在的暴露途径,它对公众健康造成了重大关注.
研究的目的:
- 在小鼠模型中研究吸入微囊素-氨酸-氨酸 (MC-LR) 的健康影响和毒性.
- 确定MC-LR在通气道上皮质及其目标器官的转移潜力.
- 为了确定MC-LR的潜在可接受的吸入剂量.
主要方法:
- 对雄性和雌性小鼠,MC-LR被注射入鼻,剂量各不相同.
- 监测老鼠的死亡率,临床症状和病理变化.
- 分析了肺和肝组织的炎症,MC-LR的存在和基因表达变化.
- 用一个3D人体气道模型来评估MC-LR转位.
主要成果:
- 吸入的MC-LR在小鼠中引起了剂量依赖的死亡率,雌性显示出更高的敏感性.
- 在受影响的小鼠中观察到严重的肝堵塞和肝毒性.
- 在暴露后2小时内,在肝脏组织中检测到MC-LR,并在呼吸道上皮上转移.
- 肝脏基因表达发生显著变化,包括ATF3和NR4A1的上调和miR-122的下调.
结论:
- 吸入的MC-LR诱导肝脏特异性毒性,主要通过肝脏拥堵.
- 建议MC-LR可接受的吸入剂量低于10μg/kg.
- 由于水污染的增加,对长期暴露于MC-LR环境度的进一步研究是有必要的.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
208
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
208
Acute Respiratory Failure-III
749
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
749
Toxic Reactions: Overview
1.8K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K
Hepatic Drug Excretion: Enterohepatic Cycling
2.6K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.6K
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K
Inflammatory Bowel Disease I: Ulcerative Colitis
880
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
880


